Repligen Corporation (RGEN) Income Statement
RGEN 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsRGEN revenue and net income
Where RGEN's revenue goes
2025Each bar shows an amount and its share of revenue. RGEN kept 6.6% of revenue as net income.
RGEN profit margins
RGEN growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +16.4% | −2.7% | +15.0% | +24.3% |
| Gross profit | +26.6% | −8.6% | +12.3% | +21.8% |
| Operating income | — | −35.8% | −6.0% | +15.8% |
| Net income | — | −35.9% | −4.0% | +18.0% |
| EPS (diluted) | +64.4% | −19.5% | +0.6% | +19.4% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
RGEN quarterly EPS vs estimates
Repligen beat the analyst EPS estimate in 6 of the last 8 quarters. Next report: October 27, 2026 (estimate $0.46).
RGEN income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $738.3M | $634.4M | $638.8M | $801.5M | $670.5M | $366.3M | $270.2M | $194.0M | $141.2M | $104.5M |
| Cost of revenue | $390.6M | $359.8M | $354.5M | $345.8M | $279.3M | $171.9M | $132.0M | $86.0M | $67.0M | $47.1M |
| Gross profit | $347.6M | $274.6M | $284.2M | $455.7M | $391.3M | $194.4M | $138.2M | $108.1M | $74.2M | $57.4M |
| Research & development | $54.2M | $43.2M | $42.7M | $43.9M | $34.3M | $19.7M | $19.4M | $15.8M | $8.7M | $7.4M |
| Sales, general & admin | $290.5M | $263.4M | $213.8M | $215.8M | $183.9M | $119.6M | $95.6M | $66.3M | $51.5M | $30.9M |
| Total operating expenses | $288.0M | $309.8M | $230.3M | $231.0M | $224.0M | $113.1M | $98.1M | $82.1M | $60.2M | $38.2M |
| Operating income | $59.6M | −$35.1M | $54.6M | $224.7M | $167.2M | $81.3M | $40.1M | $26.0M | $14.0M | $16.0M |
| Interest income | — | — | — | — | — | — | $4.0M | $4.8M | $6.1M | $3.4M |
| Interest expense | $23.2M | $22.6M | $10.0M | $3.0M | $12.7M | $12.1M | $9.3M | $6.7M | $6.4M | $3.8M |
| Income before taxes | $62.4M | −$27.0M | $64.1M | $219.1M | $153.5M | $59.2M | $26.2M | $21.4M | $7.2M | $11.7M |
| Income taxes | $13.5M | −$1.5M | $22.6M | $33.2M | $25.3M | −$709,000 | $4.7M | $4.8M | −$21.1M | $11,000 |
| Net income | $48.9M | −$25.5M | $41.6M | $186.0M | $128.3M | $59.9M | $21.4M | $16.6M | $28.4M | $11.7M |
| EBITDA | $182.5M | $80.3M | $124.3M | $277.3M | $203.3M | $98.4M | $56.3M | $41.8M | $24.2M | $24.6M |
| EPS (diluted) | $1.71 | $1.04 | $1.73 | $3.28 | $3.06 | $1.66 | $1.05 | $0.74 | $0.70 | $0.44 |
| Gross margin | 47.1% | 43.3% | 44.5% | 56.9% | 58.3% | 53.1% | 51.1% | 55.7% | 52.5% | 54.9% |
| Operating margin | 8.1% | −5.5% | 8.5% | 28.0% | 24.9% | 22.2% | 14.8% | 13.4% | 9.9% | 15.3% |
| Net margin | 6.6% | −4.0% | 6.5% | 23.2% | 19.1% | 16.4% | 7.9% | 8.6% | 20.1% | 11.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $204.1M | $194.3M | $197.9M | $188.8M | $182.4M | $169.2M | $167.5M | $154.9M | $154.1M | $153.2M | $155.7M | $141.2M |
| Cost of revenue | $95.8M | $95.8M | $104.5M | $88.3M | $91.2M | $78.4M | $128.7M | $77.4M | $85.3M | $76.4M | $88.1M | $104.6M |
| Gross profit | $108.4M | $98.5M | $93.4M | $100.5M | $91.1M | $90.8M | $38.8M | $77.5M | $68.8M | $76.8M | $67.6M | $36.6M |
| Research & development | $14.4M | $14.5M | $12.2M | $14.2M | $14.0M | $12.9M | $11.7M | $9.7M | $10.6M | $11.2M | $10.3M | $10.6M |
| Sales, general & admin | $76.6M | $76.5M | $86.0M | $73.7M | $71.2M | $71.3M | $61.0M | $75.6M | $64.7M | $61.8M | $57.5M | $55.5M |
| Total operating expenses | $96.4M | $80.5M | $74.9M | $83.7M | $77.2M | $84.2M | $75.3M | $85.3M | $75.3M | $73.0M | $68.5M | $31.9M |
| Operating income | $11.9M | $18.0M | $18.6M | $16.8M | $13.9M | $6.6M | −$36.5M | −$7.8M | $1.5M | $3.8M | −$887,000 | $4.7M |
| Interest expense | $17.2M | $6.0M | $5.9M | $27.4M | $5.8M | $5.7M | $5.5M | $5.6M | $5.5M | $5.5M | $8.0M | $867,000 |
| Income before taxes | $14.2M | $1.8M | $19.1M | $17.1M | $18.2M | $7.9M | −$38.6M | −$1.1M | $5.2M | $3.7M | −$8.8M | $11.4M |
| Income taxes | $9.1M | −$6.6M | $5.8M | $2.2M | $3.3M | $2.1M | −$4.7M | −$495,000 | $1.9M | $399,000 | $16.7M | −$5.5M |
| Net income | $5.0M | $8.3M | $13.3M | $14.9M | $14.9M | $5.8M | −$33.9M | −$654,000 | $3.3M | $3.3M | −$25.5M | $16.9M |
| EBITDA | $45.9M | $32.3M | $49.6M | $46.9M | $48.3M | $36.4M | $2.1M | $25.4M | $27.4M | $30.0M | $17.0M | $31.6M |
| EPS (diluted) | $0.54 | $0.48 | $0.49 | $0.46 | $0.37 | $0.39 | $0.44 | −$0.01 | $0.33 | $0.28 | $0.33 | $0.23 |
| Gross margin | 53.1% | 50.7% | 47.2% | 53.2% | 50.0% | 53.6% | 23.2% | 50.0% | 44.6% | 50.1% | 43.4% | 25.9% |
| Operating margin | 5.8% | 9.3% | 9.4% | 8.9% | 7.6% | 3.9% | −21.8% | −5.1% | 1.0% | 2.4% | −0.6% | 3.3% |
| Net margin | 2.5% | 4.3% | 6.7% | 7.9% | 8.2% | 3.4% | −20.2% | −0.4% | 2.2% | 2.2% | −16.4% | 12.0% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in RGEN's financial statements (latest annual report filed February 26, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
RGEN financial results
In fiscal year 2025 (ended December 31, 2025), Repligen reported revenue of $738.3 million, up 16.4% from the year before. It had net income of $48.9 million, a net profit margin of 6.6%. Diluted earnings per share came to $1.71. Over five years revenue grew at an average rate of 15.0% a year.
See the RGEN stock overview for the latest quote and news, or the RGEN chart for price history and technical indicators.
RGEN income statement FAQ
What is Repligen's annual revenue?
Repligen reported total revenue of $738.3 million for fiscal year 2025, which ended on December 31, 2025. That was up 16.4% from $634.4 million the previous year.
Is Repligen profitable?
Yes. Repligen reported net income of $48.9 million in fiscal 2025, a net profit margin of 6.6%; its operating margin was 8.1%.
What is Repligen's gross margin?
Repligen's gross margin was 47.1% in fiscal 2025: for every $100 of revenue, Repligen kept $47 after the direct cost of its products and services.
How much does Repligen spend on research and development?
Repligen spent $54.2 million on research and development in fiscal 2025, 7.3% of revenue.
How fast is Repligen growing?
Revenue grew 15.0% a year on average over the last five fiscal years, from $366.3 million to $738.3 million.
What are Repligen's earnings per share?
Repligen earned $1.71 per diluted share in fiscal 2025, compared with $1.04 a year earlier.
When will Repligen report its next earnings?
Repligen is expected to report results for the quarter ending September 30, 2026 on October 27, 2026 before the market opens.
When does Repligen's fiscal year end?
Repligen's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 26, 2026.